Membrane preparations from striatum of pig brain contain endopeptidase activity towards iodoinsulin B-chain. Only 50% of the hydrolysis of insulin B-chain is inhibitable by phosphoramidon, and DEAE-cellulose chromatography can resolve the phosphoramidon-sensitive and -insensitive activities. The former activity (now designated
) is an integral glycoprotein located in the plasma membrane of many tissues . The endopeptidase resembles thermolysin (EC 3.4.24.4) in its specificity and its sensitivity to inhibition by phosphoramidon and thiorphan (Fulcher et al., 1982) . Kidney microvilli are a particularly rich source of the endopeptidase, where it constitutes 4% of the membrane protein ).
An enzyme with similar characteristics is also present in mammalian brain, although in much lower concentration, and has been shown to inactivate the neuropeptide enkephalin by hydrolysis of the Gly3-Phe4 bond (Fulcher et al., 1982; Roques et al., 1980; Gorenstein & Snyder, 1979) . The brain enzyme has therefore been referred to in the literature as 'enkephalinase'. This is a misnomer, since the brain enzyme appears to be immunologically identical with kidney endopeptidase-24.11 and can hydrolyse a range of neuropeptide substrates including Substance P , cholecystokinin (Deschodt-Lanckman & Strosberg, 1983) , luliberin ('luteinizing hormone-releasing hormone', 'LH-RH') and neurotensin (S. H. Ibbotson, A. J. Kenny & A. J. Turner, unpublished work) . We have postulated that endopeptidase-24.11 may play a key role in the inactivation of peptide neurotransmitters at the synapse (Fulcher et al., 1982; Matsas et al., 1983) .
Previous attempts to purify the endopeptidase from brain have met with limited success (Gorenstein & Snyder, 1979; Almenoff et al., 1981) . In the present paper we report the purification of the endopeptidase from pig brain by immunoadsorbent chromatography employing a monoclonal antibody (GK7C2) to the pig kidney enzyme (Gee et al., 1983) . The brain and kidney enzymes are identical in many respects, although there are small differences in the nature and extent of their glycosylation. Evidence is also presented for the occurrence in brain of a membrane endopeptidase insensitive to phosphoramidon. (Fulcher et al., 1982; Matsas et al., 1983) .
Experimental procedures
Kidney and intestinal endopeptidase-24.11 were purified to homogeneity by immunoadsorbent chromatography as described previously . The immunoadsorbent column, containing monoclonal antibody (GK7C2), was prepared as described elsewhere (Gee et al., 1983) . The particular column used for preparation of the brain enzyme had not previously been used for purification of kidney enzyme, in order to exclude the possibility of cross-contamination. Pig brains were kindly provided by Asda Farm Products, Lofthousegate, West Yorkshire, U.K.
Assay ofendopeptidase-24.11
Two procedures were routinely used for the assay of the endopeptidase. The first method employed [23Illiodoinsulin B-chain (5.8,UM) as substrate . The second method used [D-Ala2,Leu5 lenkephalin (0.5 mM) as substrate . The sensitivity of the enzyme activity to phosphoramidon was checked at all stages of purification. Purification ofendopeptidase-24.11 from pig brain All procedures were carried out at 40C unless stated otherwise. Striata (130g) were dissected out from fresh pig brains and homogenized in 5 vol. of 10mM-Tris/HCl, pH 7.5. A membrane fraction was prepared by centrifugation of the homogenate at 17000g for 60min. The pellet was washed in half the original volume of buffer, re-centrifuged and then resuspended in 150 ml of 50mM-Tris/HCl, pH 7.5, to which 25 ml of 20% (w/v) Triton X-100 was added. After being stirred for 1 h at room temperature, the mixture was centrifuged at 31 000g for 2 h. The supernatant. containing the membrane-solubilized endopeptidase, was retained and NaCl added to a final concentration of 0.5 M. The enzyme preparation was applied at a rate of 10ml/h to the immunoadsorbent column (400,u1 bed volume), equilibrated in 50mM-Tris/HCl buffer (pH 7.5)/ 0.5M-NaCl/0.1% Triton X-100. The column was washed with 200vol. of equilibration buffer and activity eluted at room temperature with 0.1 MNaHCO3/0.5M-NaCl/0.1% Triton X-100, adjusted to pH 10.6 with 2M-NaOH. The active fractions were immediately adjusted to pH7.5, pooled, and dialysed against 5 mM-Tris/HCl (pH 7.5)/0.1% Triton X-100. The enzyme sample was then concentrated by adsorption to a small column (1001ul bed vol.) of DEAE-cellulose equilibrated in dialysis buffer, followed by elution in the same buffer containing 0.5M-NaCl. The enzyme was routinely stored frozen at -700C. After each use, the immunoadsorbent column was washed with 20 ml of 0.2 M-glycine/HCl, pH 2.3, containing 0.5 M-NaCl and 0.1% (w/v) Triton X-100 and then reequilibrated with the starting buffer solution. Between uses the column was stored with 0.02% NaN3 in this buffer.
Other methods
For some studies, the Triton-solubilized membrane preparation was initially subjected to ionexchange chromatography. The sample (0.84 g of protein) was applied to a column (60 ml bed vol.) of DEAE-cellulose equilibrated with 5 mM-Tris/HCl (pH 7.5)/0.1% Triton X-100. After the column had been washed extensively with equilibration buffer, enzyme activity was eluted by application of a linear gradient (0-300 mM-NaCl) in 1 litre of the same buffer. Fractions were collected and assayed, in the presence or absence of lpM-phosphoramidon, for endopeptidase activity using [P25Iliodoinsulin Bchain or [D-Ala2,Leu5lenkephalin as substrate. Gel filtration of the purified endopeptidase was performed on a column (530mmx22mm) of Ultrogel AcA 34. Samples (20,ug in 0.5 ml) of either brain or kidney endopeptidase were applied to the column, which was equilibrated with 10mM-Tris/HCl (pH7.5)/l00mM-NaCl/0.1% (w/v) Triton X-100. The column was calibrated with markers as described previously . SDS/polyacrylamide-gel electrophoresis was performed by using the method of Laemmli (1970) , with a 7-17% gradient of polyacrylamide.
Double immunodiffusion was carried out by the technique of Ouchterlony (1968) , with agarose (1%) containing 0.1% (w/v) Triton X-100 in 0.15M-NaCl/0.01 M-NaH2PO0.02% NaN3, adjusted with 2 M-NaOH to pH 7.4, as the diffusion medium. The central well contained polyclonal antiserum (36,ug) to the pig kidney endopeptidase. Samples (2,ug) of purified endopeptidase from kidney, intestine and brain in 5 mM-Tris/HCl/500 mM-NaCl/0. 1% Triton X-100, pH 7.5, were loaded into the peripheral wells. Immunodiffusion was allowed to occur at 40C for 48 h in a damp atmosphere. When precipitation appeared complete, unprecipitated antibodies were removed from the gel by soaking in 0.5 M-NaCl and the precipitin arcs were stained for protein with 0.5% (w/v) Coomassie Brilliant Blue R-250 in ethanol/ acetic acid/water (9:2:9, by vol. ) the more general name 'endopeptidase-24.11', on the basis of its Enzyme Commission number. This enzyme is the principal subject of the present report.
The nature and specificity of the phosphoramidon-insensitive activity are at present unclear. On DEAE-cellulose chromatography, this activity was eluted as a broad peak (120-180mM-NaCl), whereas the peak of endopeptidase-24. 11 appeared at 80 mM-NaCl. The phosphoramidoninsensitive peak was strongly inhibited by 1,10-phenanthroline and EDTA in the range 0.1-1mM, but was not inhibited by phenylmethanesulphonyl fluoride, di-isopropyl fluorophosphate (each 1 mM), leupeptin or pepstatin (each 25,ug/ml). Although it failed to hydrolyse [D-Ala2,Leu5]enkephalin, it must be considered as a potential candidate for the metabolism of other brain peptides. It is possible that it may prove to be similar to the phosphoramidoninsensitive membrane endopeptidases present in mouse (Beynon et al., 1981) and rat (Kenny et al., 1981) kidneys and other tissues , but further speculation on its role must await its purification and determination of its specificity.
Purification ofendopeptidase-24.11
The striatum is one of the richest sources of endopeptidase-24. 11 in pig brain and this region was therefore selected for purification purposes. After solubilization of enzyme activity with Triton X-100, it proved possible to purify the endopeptidase to homogeneity in a single immunoadsorbent step using our monoclonal antibody, GK7C2. An overall purification of 23 000-fold was achieved, with a yield of 30% (Table 1 , mean result for two preparations). The yield of pure endopeptidase was about lug/g (wet weight) of pig striatum by this procedure. The specific activity of the final product (160 nmol/min per mg) was the same as that of the pig kidney endopeptidase . The overall purification factor for endopeptidase-24.11 was not influenced by the use of either insulin B-chain or [D-Ala2,Leu5 Ienkephalin as substrate (Table 1) .
Immunological cross-reactivity
We had previously shown that a polyclonal antiserum to the pig kidney endopeptidase was able to inhibit kidney and brain enzymes identically ; indeed, the similarity was closer for these two than for the renal and intestinal enzymes . The ability of GK7C2 to recognize the brain endopeptidase provides additional evidence for their immunological similarity. By Ouchterlony immunodiffusion the endopeptidase purified from pig brain, intestine and kidney cross-reacted identically with the polyclonal antiserum rasied to the kidney enzyme ( Fig.   1 ).
Kinetic and inhibitor properties
The purification brain endopeptidase was inhibited by phosphoramidon in a dose-dependent manner with an I50 (concentration causing halfmaximal inhibition) (9 nM) comparable with that reported for the kidney enzyme or intact synaptic membranes (Fulcher et al., 1982) . The chelating agent 1, 10-phenanthroline (I50 145,uM) also inhibited the brain endopeptidase. Captopril (1 mM) and diisopropyl fluorophosphate (1 mM) had no effect on the purified enzyme, and 1 mM-puromycin gave 10% inhibition of brain endopeptidase activity. Again, these values are comparable with those obtained with kidney enzyme or intact synaptic membranes (Fulcher et al., 1982; Matsas et al., 1983) . The Km for hydrolysis of [D-Ala2,Leu5 ]-enkephalin was 104 gM (mean for three experiments) (cf. Km for kidney enzyme, 87 pM). The peptides produced by hydrolysis of Substance P by the purified brain enzyme had identical retention times ; results not shown).
Molecular properties ofbrain endopeptidase-24.11
When subjected to SDS/polyacrylamide-gel electrophoresis, the brain endopeptidase migrated slightly faster than the kidney enzyme (Fig. 2) . This was a consistent observation with four successive preparations. The brain enzyme revealed a single component of apparent subunit Mr 87000 (cf. kidney, 89000). In contrast, the intestinal endopeptidase migrated slower than the kidney enzyme (Fig. 2) , a difference that has been attributed to differences in glycosylation . The brain enzyme contained about 13% carbohydrate, if glucose is excluded (Table 2 ). This content is less than that of the kidney or intestinal preparations enzyme also appeared to be slightly smaller than the kidney enzyme when subjected to gel filtration on Ultrogel AcA 34. The apparent MA was 280000, consistent with a dimer binding a micelle of detergent . The amino acid composition of the brain enzyme (results not shown) compared well with those for the enzyme from kidney and intestine . Only the value for glycine showed any possible significant deviation in the three analyses, being lowest for the brain enzyme. Thus in all respects so far tested, namely specificity, kinetics, immunological and structural properties, brain endopeptidase-24. 11 appears to be identical with that of kidney. It is likely that the brain and kidney forms of the endopeptidase are products of the same gene, but are subjected to different post-translational processing in their respective tissues after translation. Since the enzyme is so much more abundant in kidney, this source has obvious advantages for studying the structure and activity of endopeptidase-24. 11.
